Biolase, Inc. (BIOL) insider have most recently took part in a trading activity. On Dec 5, 2017 Feinberg Larry N, 10% Owner bought 12,545,615 shares having total worth of $5,394,614 at the price of $0.43 per share, following the transaction a total of 30,866,265 shares owned by Feinberg Larry N.
Furthermore, over the past 12 months , the stock was traded 1 times by insiders. an employee of the company was the buyer in 1 instances.
Shares of Biolase, Inc. (BIOL) traded up 8.97% on Dec 5, 2017, hitting $0.43. 1,446,155 shares of the company’s stock traded hands. Biolase, Inc. has a 52 week low of $0.39 and a 52 week high of $1.93. The company’s market cap is $107 million.
Biolase, Inc. (BIOL) last announced its earnings results on Nov 1, 2017. The company reported -0.05 earnings per share (EPS) for the quarter, lower than the consensus estimate of -0.04 by $0.01. The company had revenue of $11 million for the quarter, compared to the consensus estimate of $14 million. During the same quarter in the previous year, the company posted -0.04 earnings per share. The company’s revenue for the quarter was down 18% on a year-over-year basis.
|earnings per share||-0.05||-0.05||-0.05||-0.05||-0.04||-0.04||-0.06||-0.02||-0.08||-0.10|
Biolase Inc. was formerly known as BIOLASE Technology, Inc. The Company changed its name to BIOLASE, Inc. in May 2012. It is a medical technology company that develops, manufactures and markets laser systems for dental and medical applications. Its principal product, the Waterlase, is a laser-based hydrokinetic surgical system for cutting hard and soft tissues. The Company’s laser products are designed to achieve clinically superior performance with less pain and faster recovery times. Its dental laser systems are used for a broad range of dental procedures, including cosmetic and complex surgical applications. The Company also distributes and markets dental imaging equipment, and Diode Laser systems for numerous therapeutic applications beyond dentistry. The Company sells its products through direct sales personnel and a network of independent distributors. The Company is revolutionizing surgery in dentistry and medicine with WaterLase technology. The Company specializes in the development, manufacturing and marketing of lasers and related products to provide biological treatments that eliminate pain and are safer for patients. BIOLASE leads the global dental industry with laser systems such as the WaterLase iPlus – breaking the speed barrier in dental lasers – and the WaterLase MDX, both featuring BIOLASE patented technologies for eliminating pain and improving clinical results. The Company’s unique 940nm wavelength diode laser technology is available in the iLase diode laser system, the world’s first totally wireless dental laser, and the ezLase Total Diode Solution for oral surgery as well as teeth whitening and pain relief. The Diolase 10 laser system provides FDA indicated temporary pain relief to chiropractics and sports medicine. The Company’s vision for Biological Dentistry goes beyond lasers. Now dentists can SEE MORE dentistry with BIOLASE Imaging and DO MORE dentistry with BIOLASE lasers. BIOLASE is the exclusive distributor for NewTom Cone Beam 3D imaging systems in the U.S. and Canada. NewTom systems are considered among the world’s highest quality 3D systems in dentistry and medicine. The BIOLASE DaVinci Imaging D3D 3D x-ray system, with among the lowest radiation of any large field of view CBCT, and many other imaging products improve the speed and accuracy of diagnosis and treatment planning. Other products currently under development address ophthalmology, dermatology, orthopedics, podiatry, and other medical and consumer markets.
Latest posts by William White (see all)
- Insider Trading Review: FS Investment Corporation $FSIC - January 13, 2018
- Insider Trader Watch: ENERTOPIA CORP $ENRT - January 13, 2018
- Insider Trading in Focus: Swiss Helvetia Fund, Inc. (The) $SWZ - January 13, 2018